DAP Accreditation Standards are:

  • Outcome focused
  • Directed at the operational level
  • Goal statements of best practice
  • Directive not prescriptive
  • Identify mandatory requirements
Username: Password:

Accreditation Standards Community Neurodiagnostics

On April 3, 2017 the Diagnostic Accreditation Program (DAP) Committee approved the Community Neurodiagnostics Accreditation Standards.


How were the standards developed?

The standards development process began with a comprehensive review of current hospital-based neurodiagnostics standards by an expert advisory panel to the DAP. This panel included neurologists, physiatrists, and technologists. Once draft standards were written, DAP staff distributed them to all neurologists registered with the DAP for feedback and conducted pilot assessments at two community neurodiagnostic facilities. Knowledge gained from these pilot assessments was used to revise the draft standards, which were then forwarded to the DAP Committee for approval.


Where are these standards applicable?

These standards apply to all community neurodiagnostics facilities. The DAP defines "community neurodiagnostics" as neurodiagnostic testing performed outside of the hospital in a physician office setting. Neurodiagnostic testing includes, but is not limited to, electromyography (EMG) and nerve conduction studies (NCS).


What does this mean for community neurodiagnostics practices?

The standards are now in effect for all community neurodiagnostic facilities and will be used for DAP assessments beginning in September 2017. DAP staff will be contacting facilities to establish assessment dates in the coming months and to offer support and information about the accreditation process and these standards.


What if I have questions?

If you have questions, please contact Mr. Nav Rakhra, Accreditation Research and Development Officer at
(604) 733-7758 ext. 2308 or nrakhra@cpsbc.ca.


2017 Community Neurodiagnostics Accreditation Standards V1.1

(Effective May 3, 2017)